MedTrace Logo

The Effectiveness of Advanced Decision Support Tool (OPT-IVF) for IVF Treatment

NCT06179420 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-03-15

No results posted yet for this study

Summary

This prospective study is subject to approval of institutional medical research ethics committee. Patient undergoing second cycle IVF will be enrolled into the intervention group. Intervention involved using a clinical decision support tool, Opt-IVF to guide gonadotrophins dosing and trigger dates for a personalized controlled ovarian stimulation cycle based on the distribution of follicle sizes on day 1 and day 5, and hormone dosages given on day 1 to 4.

Patients will undergo transvaginal ultrasound exam on day 1 and day 5 of the cycle to determine the number and size of follicles present. The data is used in the Opt-IVF decision support tool to suggest Gonadotropin dosage for D5 and beyond and to recommend the antagonist start day and trigger day.

Clinical investigators will not override the Opt-IVF recommended dosage in any patients.

Conditions

  • Fertility Issues

Interventions

OTHER

total cumulative gonadotrophin usage

total dosage in IU

Sponsors & Collaborators

  • National University of Malaysia

    lead OTHER

Principal Investigators

  • Muhammad Azrai Abu, MD · Department Of Obstetrics And Gynecology, Ukm Medical Centre

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-13
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06179420 on ClinicalTrials.gov